Novartis Loses Court Case to Block Entresto Generics After FDA Denies Petition

On the heels of the FDA’s denial of its petition, a Delaware district court on Monday handed Novartis another loss in its efforts to keep the market free of Entresto copycats.

Read more about this post on Biospace